https://www.selleckchem.com/pr....oducts/deferiprone.h
Many participants in clinical trials supporting U.S. Food and Drug Administration (FDA) drug approvals are recruited from outside the United States, including from low- and middle-income countries (LMICs). Where participants are recruited for pivotal trials has implications for ethical research conduct and generalizability. To describe LMIC recruitment for pivotal trials of newly approved drugs for cancer, neurologic disease, and cardiovascular disease. Cross-sectional analysis. Pivotal trials of new cancer, cardiovascular, and neur
Like
Comment
Share
